These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 6403026

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Sensitive solid phase enzyme immunoassay for factor IX antigen and classification of hemophilia B.
    Takamatsu J, Kamiya T, Ogata K, Sugihara T, Koie K, Kato K.
    Haemostasis; 1983; 13(1):9-16. PubMed ID: 6341181
    [Abstract] [Full Text] [Related]

  • 7. Factor IX alloantibodies shorten the bovine thromboplastin coagulation time of normal human plasma.
    Orstavik KH.
    Thromb Haemost; 1981 Dec 23; 46(4):684-6. PubMed ID: 7330818
    [Abstract] [Full Text] [Related]

  • 8. Alloantibodies in hemophilia B binding to multiple factor IX epitopes.
    Thompson AR.
    Thromb Res; 1987 Apr 01; 46(1):169-74. PubMed ID: 2438804
    [No Abstract] [Full Text] [Related]

  • 9. Inhibitors to factor IX contain all IgG subclasses except IgG3.
    Orstavik KH.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990 Apr 01; 117(4):545-8. PubMed ID: 1714858
    [Abstract] [Full Text] [Related]

  • 10. Characterization of an occult inhibitor to factor IX in a haemophilia B patient.
    Miller CH, Orstavik KH, Hilgartner MW.
    Br J Haematol; 1985 Oct 01; 61(2):329-38. PubMed ID: 4041376
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Functional mapping of anti-factor IX inhibitors developed in patients with severe hemophilia B.
    Christophe OD, Lenting PJ, Cherel G, Boon-Spijker M, Lavergne JM, Boertjes R, Briquel ME, de Goede-Bolder A, Goudemand J, Gaillard S, d'Oiron R, Meyer D, Mertens K.
    Blood; 2001 Sep 01; 98(5):1416-23. PubMed ID: 11520790
    [Abstract] [Full Text] [Related]

  • 13. [Factor IX and factor IX inhibitor].
    Higasa S.
    Nihon Rinsho; 2004 Dec 01; 62 Suppl 12():647-50. PubMed ID: 15658413
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Spontaneous disappearance of an IgA anti-factor IX inhibitor in a child with Christmas disease.
    Carroll RR, Panush RS, Kitchens CS.
    Am J Hematol; 1984 Oct 01; 17(3):321-5. PubMed ID: 6475941
    [Abstract] [Full Text] [Related]

  • 16. [Immunological studies on factor IX antigen in patients with hemophilia B variant].
    Fujimura Y, Takase T, Sakai T, Shima M, Fukui H.
    Nihon Ketsueki Gakkai Zasshi; 1982 Sep 01; 45(5):952-61. PubMed ID: 7158257
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A simple method for detection of human factor IX inhibitor using ELISA.
    Takamiya O, Kinoshita S.
    Scand J Clin Lab Invest; 1997 Dec 01; 57(8):683-8. PubMed ID: 9458490
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Monoclonal antibody to an epitope on the heavy chain of factor IX missing in three hemophilia-B patients.
    Thompson AR.
    Blood; 1983 Nov 01; 62(5):1027-34. PubMed ID: 6194835
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.